Evaluation of AI-Driven LabTest Checker for Diagnostic Accuracy and Safety: Prospective Cohort Study.

AI CDSS LabTest Checker accuracy application applications artificial intelligence assessment clinical decision support systems diagnoses health care laboratory testing medical fields medical history patient patients symptom checker tool tools

Journal

JMIR medical informatics
ISSN: 2291-9694
Titre abrégé: JMIR Med Inform
Pays: Canada
ID NLM: 101645109

Informations de publication

Date de publication:
14 Aug 2024
Historique:
received: 06 02 2024
revised: 22 05 2024
accepted: 25 05 2024
medline: 16 8 2024
pubmed: 16 8 2024
entrez: 16 8 2024
Statut: epublish

Résumé

In recent years, the implementation of artificial intelligence (AI) in health care is progressively transforming medical fields, with the use of clinical decision support systems (CDSSs) as a notable application. Laboratory tests are vital for accurate diagnoses, but their increasing reliance presents challenges. The need for effective strategies for managing laboratory test interpretation is evident from the millions of monthly searches on test results' significance. As the potential role of CDSSs in laboratory diagnostics gains significance, however, more research is needed to explore this area. The primary objective of our study was to assess the accuracy and safety of LabTest Checker (LTC), a CDSS designed to support medical diagnoses by analyzing both laboratory test results and patients' medical histories. This cohort study embraced a prospective data collection approach. A total of 101 patients aged ≥18 years, in stable condition, and requiring comprehensive diagnosis were enrolled. A panel of blood laboratory tests was conducted for each participant. Participants used LTC for test result interpretation. The accuracy and safety of the tool were assessed by comparing AI-generated suggestions to experienced doctor (consultant) recommendations, which are considered the gold standard. The system achieved a 74.3% accuracy and 100% sensitivity for emergency safety and 92.3% sensitivity for urgent cases. It potentially reduced unnecessary medical visits by 41.6% (42/101) and achieved an 82.9% accuracy in identifying underlying pathologies. This study underscores the transformative potential of AI-based CDSSs in laboratory diagnostics, contributing to enhanced patient care, efficient health care systems, and improved medical outcomes. LTC's performance evaluation highlights the advancements in AI's role in laboratory medicine.

Sections du résumé

Background UNASSIGNED
In recent years, the implementation of artificial intelligence (AI) in health care is progressively transforming medical fields, with the use of clinical decision support systems (CDSSs) as a notable application. Laboratory tests are vital for accurate diagnoses, but their increasing reliance presents challenges. The need for effective strategies for managing laboratory test interpretation is evident from the millions of monthly searches on test results' significance. As the potential role of CDSSs in laboratory diagnostics gains significance, however, more research is needed to explore this area.
Objective UNASSIGNED
The primary objective of our study was to assess the accuracy and safety of LabTest Checker (LTC), a CDSS designed to support medical diagnoses by analyzing both laboratory test results and patients' medical histories.
Methods UNASSIGNED
This cohort study embraced a prospective data collection approach. A total of 101 patients aged ≥18 years, in stable condition, and requiring comprehensive diagnosis were enrolled. A panel of blood laboratory tests was conducted for each participant. Participants used LTC for test result interpretation. The accuracy and safety of the tool were assessed by comparing AI-generated suggestions to experienced doctor (consultant) recommendations, which are considered the gold standard.
Results UNASSIGNED
The system achieved a 74.3% accuracy and 100% sensitivity for emergency safety and 92.3% sensitivity for urgent cases. It potentially reduced unnecessary medical visits by 41.6% (42/101) and achieved an 82.9% accuracy in identifying underlying pathologies.
Conclusions UNASSIGNED
This study underscores the transformative potential of AI-based CDSSs in laboratory diagnostics, contributing to enhanced patient care, efficient health care systems, and improved medical outcomes. LTC's performance evaluation highlights the advancements in AI's role in laboratory medicine.

Identifiants

pubmed: 39149851
pii: v12i1e57162
doi: 10.2196/57162
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e57162

Informations de copyright

© Dawid Szumilas, Anna Ochmann, Katarzyna Zięba, Bartłomiej Bartoszewicz, Anna Kubrak, Sebastian Makuch, Siddarth Agrawal, Grzegorz Mazur, Jerzy Chudek. Originally published in JMIR Medical Informatics (https://medinform.jmir.org).

Auteurs

Dawid Szumilas (D)

Department of Internal Medicine and Oncological Chemotherapy, Medical University of Silesia, Reymonta St. 8, Katowice, 40-027, Poland, +48 32 2591 202.

Anna Ochmann (A)

Department of Internal Medicine and Oncological Chemotherapy, Medical University of Silesia, Reymonta St. 8, Katowice, 40-027, Poland, +48 32 2591 202.

Katarzyna Zięba (K)

Department of Internal Medicine and Oncological Chemotherapy, Medical University of Silesia, Reymonta St. 8, Katowice, 40-027, Poland, +48 32 2591 202.

Anna Kubrak (A)

Labplus R&D, Wroclaw, Poland.

Sebastian Makuch (S)

Department of Clinical and Experimental Pathology, Wroclaw Medical University, Wroclaw, Poland.

Grzegorz Mazur (G)

Labplus R&D, Wroclaw, Poland.
Department and Clinic of Internal Medicine, Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, Wroclaw, Poland.

Jerzy Chudek (J)

Department of Internal Medicine and Oncological Chemotherapy, Medical University of Silesia, Reymonta St. 8, Katowice, 40-027, Poland, +48 32 2591 202.

Classifications MeSH